VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$521.12
arrow_downward
-1.47%(-7.78) 1D
$521.12
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 9, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$524.00
High
$528.16
Low
$520.08
Mkt. cap
132.08B
Avg. vol.
1.19M
Volume
0.00
P/E ratio
30.32
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
Open
$524.00
High
$528.16
Low
$520.08
Mkt. cap
132.08B
Avg. vol.
1.19M
Volume
0.00
P/E ratio
30.32
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
TradingView
·
7 hours ago
VRTX: Upcoming renal and pain launches, pivotal data, and global expansion drive growth outlook
ad-hoc-news.de
·
9 hours ago
Vertex Pharma stock falls as market digests Crinetics deal and valuation risks
Simply Wall Street
·
12 hours ago
Vertex (VRTX) Stock Still Looks Like A Bargain On Its 181% Run
Kalkine Media
·
16 hours ago
Where does Vertex Pharmaceuticals (NASDAQ:VRTX) fit within the Healthcare stocks conversation?
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com